Bristol-Myers Squibb (BMY) News Today → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free BMY Stock Alerts $44.11 -0.44 (-0.99%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 10:00 PM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Holdings Decreased by Beacon Pointe Advisors LLCBeacon Pointe Advisors LLC decreased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 16.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 310,941 shares of the biopharmMay 16 at 8:07 PM | finance.yahoo.comWalmart Earnings & the State of the ConsumerMay 16 at 5:36 PM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Trading Down 1.6%Bristol-Myers Squibb (NYSE:BMY) Shares Down 1.6%May 16 at 4:02 PM | stocknews.com3 Pharma Stocks Primed for May Investment OpportunitiesMay 16 at 10:26 AM | businesswire.comNew Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque PsoriasisMay 16 at 7:15 AM | investorplace.com7 Pharma Stocks Harnessing AI Brainpower for Big BreakthroughsMay 16 at 7:08 AM | marketbeat.comBristol-Myers Squibb Q1 Earnings TranscriptMay 16 at 12:08 AM | finance.yahoo.comBristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular LymphomaMay 15 at 8:57 PM | businesswire.comBristol Myers Squibb's CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular LymphomaMay 15 at 8:10 PM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Up 0.2%Bristol-Myers Squibb (NYSE:BMY) Trading 0.2% HigherMay 15 at 7:58 PM | seekingalpha.comBristol-Myers Squibb Company (BMY) Bank of America Global Healthcare Conference 2024 TranscriptMay 15 at 7:55 PM | marketbeat.comLmcg Investments LLC Reduces Stock Position in Bristol-Myers Squibb (NYSE:BMY)Lmcg Investments LLC decreased its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 93.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,841 shares of the biopharmaceutical company'sMay 15 at 7:08 PM | finance.yahoo.comUPDATE 2-US FDA approves expanded use of Bristol Myers' cancer cell therapyMay 15 at 5:01 PM | reuters.comUS FDA approves expanded use of Bristol's cancer cell therapyMay 15 at 2:14 AM | americanbankingnews.comHead-To-Head Analysis: Bristol-Myers Squibb (NYSE:BMY) vs. Amylyx Pharmaceuticals (NASDAQ:AMLX)May 14 at 5:53 PM | marketbeat.comJanney Montgomery Scott LLC Purchases 96,733 Shares of Bristol-Myers Squibb (NYSE:BMY)Janney Montgomery Scott LLC grew its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 12.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 851,388 shares of the biopharmaceutical company's stock after buying an additMay 14 at 2:54 PM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Down 0.5% Bristol-Myers Squibb (NYSE:BMY) Stock Price Down 0.5%May 14 at 6:46 AM | investorplace.comDividend Capture Captains: The 3 Best Blue-Chip Stocks for Tactical TradersMay 13, 2024 | finance.yahoo.comThese Stocks Moved the Most Today: GameStop, AMC, Arm, Squarespace, Walgreens, Tesla, Intel, Apple, and MoreMay 13, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Trading 0.5% Higher Bristol-Myers Squibb (NYSE:BMY) Shares Up 0.5%May 13, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Principal Financial Group Inc.Principal Financial Group Inc. cut its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 11.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,424,604 shares of the biopharmaceuticalMay 13, 2024 | seekingalpha.comBristol-Myers Squibb Company (BMY) Presents at Guggenheim Securities Radiopharmaceuticals Day (Transcript)May 13, 2024 | americanbankingnews.comZacks Research Weighs in on Bristol-Myers Squibb's FY2024 Earnings (NYSE:BMY)May 12, 2024 | marketbeat.com19,362 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by Partnership Wealth Management LLCPartnership Wealth Management LLC purchased a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 19,362 shares of tMay 12, 2024 | americanbankingnews.comBristol-Myers Squibb (NYSE:BMY) Stock Price Down 0%May 12, 2024 | fool.comDown but Not Out: 3 Stocks to Buy on a Post-Earnings DipMay 11, 2024 | marketbeat.comDimensional Fund Advisors LP Buys 1,246,066 Shares of Bristol-Myers Squibb (NYSE:BMY)Dimensional Fund Advisors LP lifted its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 7.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 16,959,807 shares of the biopharmaceutical company's stock after acquiring an addMay 11, 2024 | fool.comIs Bristol Myers' Dividend in Danger?May 11, 2024 | americanbankingnews.comZacks Research Research Analysts Reduce Earnings Estimates for Bristol-Myers Squibb (NYSE:BMY)May 10, 2024 | marketbeat.comArcadia Investment Management Corp MI Reduces Stock Position in Bristol-Myers Squibb (NYSE:BMY)Arcadia Investment Management Corp MI cut its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 64.4% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 39,128 shares of the biopharmaceutical company's stock after selliMay 10, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Down 0% Bristol-Myers Squibb (NYSE:BMY) Stock Price Down 0%May 10, 2024 | finance.yahoo.comBristol Myers Squibb Cancer-Treatment Trial Misses EndpointMay 10, 2024 | businesswire.comBristol Myers Squibb Provides Update on Phase 3 CheckMate -73L TrialMay 10, 2024 | marketbeat.comBounce Alert: 3 Large Caps With RSIs Too Good To IgnoreSavvy stock investors often look for bargains using the Relative Strength Index (RSI). This technical tool evaluates a stock's performance over the last 14 days and assigns a value from 0 to 100.May 10, 2024 | marketbeat.comBounce Alert: 3 Large Caps With RSIs Too Good To Ignore (BMY)The sudden divergence has made clear some laggards who have ultra-low RSI readings that might just be too good to ignore. Here are 3 worth watching closely.May 10, 2024 | fool.com2 Beaten-Down Stocks to Buy and Hold for 10 YearsMay 10, 2024 | marketbeat.comResearch Analysts Offer Predictions for Bristol-Myers Squibb's Q2 2024 Earnings (NYSE:BMY)Bristol-Myers Squibb (NYSE:BMY - Free Report) - Research analysts at Zacks Research reduced their Q2 2024 earnings per share estimates for shares of Bristol-Myers Squibb in a report issued on Thursday, May 9th. Zacks Research analyst E. Bagri now forecasts that the biopharmaceutical company willMay 9, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Trading Up 0.5%Bristol-Myers Squibb (NYSE:BMY) Shares Up 0.5%May 9, 2024 | marketbeat.comNational Pension Service Grows Position in Bristol-Myers Squibb (NYSE:BMY)National Pension Service boosted its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 2.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,738,757 shares of the biopharmaceutical company's stock after buying an additional 79,1May 8, 2024 | marketbeat.comCullen Frost Bankers Inc. Sells 40,307 Shares of Bristol-Myers Squibb (NYSE:BMY)Cullen Frost Bankers Inc. trimmed its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 12.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 280,687 shares of the biopharmaceutiMay 8, 2024 | finance.yahoo.comQ1 2024 Editas Medicine Inc Earnings CallMay 8, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Trading Down 0.3%Bristol-Myers Squibb (NYSE:BMY) Trading Down 0.3%May 8, 2024 | finance.yahoo.comBristol-Myers Squibb Insiders Sell US$1.1m Of Stock, Possibly Signalling CautionMay 7, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Acquires 134,815 Shares of Bristol-Myers Squibb (NYSE:BMY)Charles Schwab Investment Management Inc. raised its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 1.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,3May 7, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Up 0.3%Bristol-Myers Squibb (NYSE:BMY) Trading 0.3% HigherMay 7, 2024 | businesswire.comBristol Myers Squibb to Participate in Upcoming Investor ConferencesMay 6, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Down 0.1% Bristol-Myers Squibb (NYSE:BMY) Stock Price Down 0.1%May 6, 2024 | investorplace.comMaximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ YieldsMay 6, 2024 | markets.businessinsider.comBristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA ValidationMay 6, 2024 | marketbeat.comMerit Financial Group LLC Sells 25,473 Shares of Bristol-Myers Squibb (NYSE:BMY)Merit Financial Group LLC cut its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 56.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,024 shares of the biopharmaceutical c Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble. Click here if you’d like to learn more about these five cryptos… BMY Media Mentions By Week BMY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMY News Sentiment▼0.580.54▲Average Medical News Sentiment BMY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMY Articles This Week▼4422▲BMY Articles Average Week Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Zoetis News Today Pfizer News Today AbbVie News Today Merck & Co., Inc. News Today GSK News Today Vertex Pharmaceuticals News Today Regeneron Pharmaceuticals News Today Sanofi News Today Takeda Pharmaceutical News Today Abbott Laboratories News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BMY) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
